PATENT CLAIM ANALYSIS

Application Number: 15957279
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "134100"]

Abstract:
Provided herein are specific GITR receptor agonist proteins, nucleic acids encoding the same, and methods of treating a subject having a GITRL-associated disease or disorder. The GITR receptor agonist proteins provided herein comprise three soluble GITRL domains and an Fc fragment. The GITR receptor agonist proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications.

Claim (Index 7):
The GITR receptor agonist protein of  claim 5 , wherein the soluble GITRL domain ends with amino acid S177 of SEQ ID NO: 1 and/or optionally comprises a mutation at position E52, A54, K55, L65A, P66A, K68A, P77, N80, V82, E88, L90, Q91, N106, N120, N129, K121, D122, V144, L159, N161, N172, P173, Q174 or at two or more of said positions.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15636711', '15014134', '15234551', '15643787', '15217754']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7561242466454645
- 35 USC 102 Novelty (BERT): 0.5435663372517482
- Combined Prediction Score: 0.7348684557060929
- Mean Citation Score: 363.87054
- Max Citation Score: 380.20157
- Similarity Product: 265.7106339656067

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test